Home »
1994 Issues »
59 FR (07/15/1994) » 94-17150. Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-The-Counter Human Use; Amendment of Final Monograph for OTC Antitussive Drug Products; Correction
94-17150. Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-The-Counter Human Use; Amendment of Final Monograph for OTC Antitussive Drug Products; Correction
[Federal Register Volume 59, Number 135 (Friday, July 15, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-17150]
[[Page Unknown]]
[Federal Register: July 15, 1994]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 341
[Docket No. 89P-0040]
RIN 0905-AA06
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug
Products for Over-The-Counter Human Use; Amendment of Final Monograph
for OTC Antitussive Drug Products; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a final
rule that appeared in the Federal Register of June 3, 1994 (59 FR
29172). The document amended the final monograph for over-the-counter
(OTC) antitussive drug products to include the ingredients
diphenhydramine citrate and diphenhydramine hydrochloride. The document
was published with some errors. This document corrects those errors.
EFFECTIVE DATE: June 5, 1995.
FOR FURTHER INFORMATION CONTACT: William E. Gilbertson, Center for Drug
Evaluation and Research (HFD-810), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-594-5000.
In FR Doc. 94-13586, appearing on page 29172 in the Federal
Register of Friday, June 3, 1994, the following corrections are made:
Sec. 341.74 [Corrected]
1. On page 29174, in the third column, in Sec. 341.74 Labeling of
antitussive drug products, paragraphs (d)(1)(iv) and (d)(1)(v) are
corrected by removing the quotation marks.
Sec. 341.90 [Corrected]
2. On page 29174, in the third column, in Sec. 341.90 Professional
labeling, paragraphs (r) and (s) are corrected by removing the
quotation marks.
Dated: July 8, 1994.
Michael R. Taylor,
Deputy Commissioner for Policy.
[FR Doc. 94-17150 Filed 7-14-94; 8:45 am]
BILLING CODE 4160-01-F
Document Information
- Published:
- 07/15/1994
- Department:
- Food and Drug Administration
- Entry Type:
- Uncategorized Document
- Action:
- Final rule; correction.
- Document Number:
- 94-17150
- Dates:
- June 5, 1995.
- Pages:
- 0-0 (1 pages)
- Docket Numbers:
- Federal Register: July 15, 1994, Docket No. 89P-0040
- RINs:
- 0905-AA06
- CFR: (2)
- 21 CFR 341.74
- 21 CFR 341.90